Skip to main content
Top
Gepubliceerd in: Tijdschrift voor Kindergeneeskunde 1/2015

01-03-2015

E-health: wat wordt/is de toekomst bij de behandeling van diabetes?

Auteurs: Dhr. dr. H.J. Veeze, dhr. dr. H.J. Aanstoot

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 1/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Gebruik van e-health bij de behandeling van diabetes lijkt soms met alle beschikbare mogelijkheden als een goed ontwikkeld gebied, maar dat blijkt niet als we naar de matige uitkomsten op lange termijn kijken van diegenen die als kind diabetes hebben ontwikkeld. Verdere verbetering is nodig en e-health zal daar een hoofdrol in vervullen. Daarom bespreekt dit artikel de veranderingen die de diabeteszorg verder kan verbeteren aan de hand van de door de minister van VWS voorgestelde drie stappen voor betere e-healthimplementatie: directe toegang van de patiënt tot het dossier, meer zelfmetingen en telemonitoring en meer beeldschermzorg en domotica. Hoewel van alle drie de gebieden losstaande voorbeelden bestaan, zijn verdergaande integratie-, implementatie-, veiligheids- en educatiestappen nodig. Verdere automatisering van bijvoorbeeld de insulinepomp en glucosesensor, het gebruik van nieuwe additionele metingen en technieken, die gezamenlijk de grote hoeveelheden gegevens verzamelen en verwerken (big data) en een andere rol van de patiënt en behandelteam hierin, zullen de diabeteszorg op korte termijn drastisch gaan veranderen.
Literatuur
1.
go back to reference Ministerie van VWS. Kamerbrief over e-health en zorgverbetering. Den Haag: VWS, 2014. Ministerie van VWS. Kamerbrief over e-health en zorgverbetering. Den Haag: VWS, 2014.
2.
go back to reference Mortensen HB, Hougaard P; Hvidøre Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care. 1997;20:714–20.PubMedCrossRef Mortensen HB, Hougaard P; Hvidøre Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care. 1997;20:714–20.PubMedCrossRef
3.
go back to reference McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2014 Dec 15. [Epub ahead of print] McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2014 Dec 15. [Epub ahead of print]
4.
go back to reference Livingstone SJ, Levin D, Looker HC, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015;313:37–44.PubMedCrossRef Livingstone SJ, Levin D, Looker HC, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015;313:37–44.PubMedCrossRef
5.
go back to reference Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972–82.PubMedCrossRef Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972–82.PubMedCrossRef
6.
go back to reference Writing Group for the DCCT/EDIC Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313:45–53.CrossRef Writing Group for the DCCT/EDIC Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313:45–53.CrossRef
7.
go back to reference Cortez NG, Cohen IG, Kesselheim AS. FDA regulation of mobile health technologies. N Engl J Med. 2014;371:372–9.PubMedCrossRef Cortez NG, Cohen IG, Kesselheim AS. FDA regulation of mobile health technologies. N Engl J Med. 2014;371:372–9.PubMedCrossRef
8.
go back to reference RIVM. Risks related to the use of eHealth technologies. Bilthoven: RIVM, 2012. RIVM. Risks related to the use of eHealth technologies. Bilthoven: RIVM, 2012.
9.
go back to reference Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the ‘dead in bed’ syndrome revisited. Diabetologia. 2009;52:42–5.PubMedCrossRef Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes – the ‘dead in bed’ syndrome revisited. Diabetologia. 2009;52:42–5.PubMedCrossRef
10.
go back to reference Koivikko ML, Tulppo MP, Kiviniemi AM, et al. Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patiënts with type 1 diabetes. Diabetes Care. 2012;35:1585–90.PubMedCentralPubMedCrossRef Koivikko ML, Tulppo MP, Kiviniemi AM, et al. Autonomic cardiac regulation during spontaneous nocturnal hypoglycemia in patiënts with type 1 diabetes. Diabetes Care. 2012;35:1585–90.PubMedCentralPubMedCrossRef
11.
go back to reference Jaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36:2351–8.PubMedCentralPubMedCrossRef Jaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36:2351–8.PubMedCentralPubMedCrossRef
12.
go back to reference Jaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36:157–62.PubMedCentralPubMedCrossRef Jaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36:157–62.PubMedCentralPubMedCrossRef
13.
go back to reference Mul D, Veeze HJ. Virtuele kindergeneeskunde. Ned Tijdschr Geneeskd. 2014;158:A8267.PubMed Mul D, Veeze HJ. Virtuele kindergeneeskunde. Ned Tijdschr Geneeskd. 2014;158:A8267.PubMed
14.
go back to reference Salzsieder E, Augstein P. The Karlsburg Diabetes Management System: translation from research to eHealth application. J Diabetes Sci Technol. 2011;5:13–22.PubMedCentralPubMedCrossRef Salzsieder E, Augstein P. The Karlsburg Diabetes Management System: translation from research to eHealth application. J Diabetes Sci Technol. 2011;5:13–22.PubMedCentralPubMedCrossRef
15.
go back to reference Drift EJG van der, Looije R, Blanson Henkemans O, Neerinx MA. A remote social robot to motivate and support diabetic children in keeping a diary. Proceedings of the 2014 ACM/IEEE International Conference on Human-robot Interaction. 2014. p. 463–70. Drift EJG van der, Looije R, Blanson Henkemans O, Neerinx MA. A remote social robot to motivate and support diabetic children in keeping a diary. Proceedings of the 2014 ACM/IEEE International Conference on Human-robot Interaction. 2014. p. 463–70.
16.
go back to reference Özcan BKN, Kok N, Wallenburg J, Sijbrands E. Diabetoloog 2.0. Ned Tijdschr Geneeskd. 2014; 158:A8451.PubMed Özcan BKN, Kok N, Wallenburg J, Sijbrands E. Diabetoloog 2.0. Ned Tijdschr Geneeskd. 2014; 158:A8451.PubMed
17.
go back to reference Cameron F, Beaufort C de, Aanstoot HJ, et al. Lessons from the Hvidøre International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach. Pediatr Diabetes. 2013;14:473–80.PubMedCrossRef Cameron F, Beaufort C de, Aanstoot HJ, et al. Lessons from the Hvidøre International Study Group on childhood diabetes: be dogmatic about outcome and flexible in approach. Pediatr Diabetes. 2013;14:473–80.PubMedCrossRef
18.
go back to reference Esmatjes E, Jansa M, Roca D, et al. The efficiency of telemedicine to optimize metabolic control inpatients with type 1 diabetes mellitus: Telemedstudy. Diabetes Technol Ther. 2014;16:435–41.PubMedCrossRef Esmatjes E, Jansa M, Roca D, et al. The efficiency of telemedicine to optimize metabolic control inpatients with type 1 diabetes mellitus: Telemedstudy. Diabetes Technol Ther. 2014;16:435–41.PubMedCrossRef
19.
go back to reference Fatehi F, Martin-Khan M, Smith AC, et al. Patient satisfaction with video teleconsultation in a virtual diabetes outreach clinic. Diabetes Technol Ther. 2015;17:43–8.PubMedCrossRef Fatehi F, Martin-Khan M, Smith AC, et al. Patient satisfaction with video teleconsultation in a virtual diabetes outreach clinic. Diabetes Technol Ther. 2015;17:43–8.PubMedCrossRef
20.
go back to reference Scheiner G. Treat George Jetson: Video chat for better patient care. Diabetes Spectr. 2013;26:215–20.CrossRef Scheiner G. Treat George Jetson: Video chat for better patient care. Diabetes Spectr. 2013;26:215–20.CrossRef
21.
go back to reference Malasanos T. Diabetes clinic at a distance: Telemedicine bridges the gap. Diabetes Spectr. 2013;26:226–31.CrossRef Malasanos T. Diabetes clinic at a distance: Telemedicine bridges the gap. Diabetes Spectr. 2013;26:226–31.CrossRef
22.
go back to reference Dendrou CA, Bell JI, Fugger L. Weighing in on autoimmune disease: Big data tip the scale. Nat Med. 2013;19:138–9.PubMedCrossRef Dendrou CA, Bell JI, Fugger L. Weighing in on autoimmune disease: Big data tip the scale. Nat Med. 2013;19:138–9.PubMedCrossRef
23.
go back to reference Weber GM, Mandl KD, Kohane IS. Finding the missing link for big biomedical data. JAMA. 2014;311:2479–80.PubMed Weber GM, Mandl KD, Kohane IS. Finding the missing link for big biomedical data. JAMA. 2014;311:2479–80.PubMed
24.
25.
go back to reference Grey M, Whittemore R, Jeon S, et al. Internet psycho-education programs improve outcomes in youth with type 1 diabetes. Diabetes Care. 2013;36:2475–82.PubMedCentralPubMedCrossRef Grey M, Whittemore R, Jeon S, et al. Internet psycho-education programs improve outcomes in youth with type 1 diabetes. Diabetes Care. 2013;36:2475–82.PubMedCentralPubMedCrossRef
26.
go back to reference Herbert L, Owen V, Pascarella L, Streisand R. Text message interventions for children and adolescents with type 1 diabetes: a systematic review. Diabetes Technol Ther. 2013;15:362–70.PubMedCrossRef Herbert L, Owen V, Pascarella L, Streisand R. Text message interventions for children and adolescents with type 1 diabetes: a systematic review. Diabetes Technol Ther. 2013;15:362–70.PubMedCrossRef
27.
go back to reference Vuong AM, Huber JC Jr, Bolin JN, et al. Factors affecting acceptability and usability of technological approaches to diabetes self-management: a case study. Diabetes Technol Ther. 2012;14:1178–82.PubMedCentralPubMedCrossRef Vuong AM, Huber JC Jr, Bolin JN, et al. Factors affecting acceptability and usability of technological approaches to diabetes self-management: a case study. Diabetes Technol Ther. 2012;14:1178–82.PubMedCentralPubMedCrossRef
Metagegevens
Titel
E-health: wat wordt/is de toekomst bij de behandeling van diabetes?
Auteurs
Dhr. dr. H.J. Veeze
dhr. dr. H.J. Aanstoot
Publicatiedatum
01-03-2015
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 1/2015
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/s12456-015-0010-8

Andere artikelen Uitgave 1/2015

Tijdschrift voor Kindergeneeskunde 1/2015 Naar de uitgave

Editorial

Editorial